Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00349128

Femme et Homme

Extrait

The primary objective was to assess the effect of 3-month treatment of low and standard doses of fenofibrate in combination with stable dose of metformin on fasting triglycerides levels in patients with type 2 diabetes and dyslipidemia.


Critère d'inclusion

  • Dyslipidemia/Glucose Metabolism Disorder

Liens